Evidence map›Paper›PMID 31774523›Full record

ArticleJAMA network open2019

Trends in Diabetic Retinopathy, Visual Acuity, and Treatment Outcomes for Patients Living With Diabetes in a Fundus Photograph-Based Diabetic Retinopathy Screening Program in Bangladesh.

Mahiul M K Muqit, Nick Kourgialis, Meredith Jackson-deGraffenried, Zaman Talukder, Erica R Khetran, Arifur Rahman, Weng Onn Chan, Fakrhul A Chowdury, Dipak Nag, Jasmin Ahmad and 1 more

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Telemedicine in diabetic retinopathy screening in India.Indian journal of ophthalmology · 2021
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Mahiul M K MuqitVitreoretinal Service, Moorfields Eye Hospital, National Health Service Trust, London, United Kingdom.
Nick KourgialisHelen Keller International, New York, New York.
Meredith Jackson-deGraffenriedHelen Keller International, Dhaka, Bangladesh.
Zaman TalukderHelen Keller International, Dhaka, Bangladesh.
Erica R KhetranHelen Keller International, New York, New York.
Arifur RahmanHelen Keller International, Dhaka, Bangladesh.
Weng Onn ChanDepartment of Ophthalmology and Visual Sciences, University of Adelaide, Adelaide, South Australia, Australia.
Fakrhul A ChowduryHelen Keller International, Dhaka, Bangladesh.
Dipak NagRetina Service, National Institute of Ophthalmology and Hospital, Dhaka, Bangladesh.
Jasmin AhmadRetina Service, Chittagong Eye Infirmary and Training Complex, Chittagong, Bangladesh.
David S FriedmanMassachusetts Eye and Ear, Harvard Medical School, Boston.
Dhaka International University · BDHelen Keller International · USHarvard University · USNational Health Service · GBNational Institute of Neurosciences & Hospital · BDUniversity of Adelaide · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Diabetic retinopathy (DR) is the leading cause of low vision among working-age adults. An estimated 6.9 million people in Bangladesh were living with diabetes in 2017, which is projected to increase to more than 10 million people in 2025. Currently, no standardized and/or large-scale DR screening program exists in Bangladesh. Objective: To develop a novel fundus photograph-based eye screening model for early detection of DR to prevent vision loss in Bangladeshi individuals with diabetes. Design, Setting, and Participants: In this cross-sectional study, 49 264 patients with diabetes underwent opportunistic eye screening at 2 eye hospitals and 1 diabetic hospital in Bangladesh between June 1, 2010, and September 30, 2017. The data set was analyzed from April 8 to December 30, 2018. Technicians were trained to obtain 2-field digital fundus photographs and to grade each according to a standardized DR severity scale. Each patient was counseled and triaged for treatment using defined DR referral criteria. Main Outcomes and Measures: Primary DR grading outcomes, visual acuity, and treatment outcomes. Results: A total of 49 264 patients (54.3% male; mean [SD] age, 50.8 [12.3] years) underwent DR screening during a 7-year period. The DR prevalence rate across all 3 sites was 33% (95% CI, 33%-33%). Prevalence rates varied by center (Chittagong, 64.6% [95% CI, 64.0%-65.0%]; Dhaka, 39.8% [95% CI, 39.0%-41.0%]; and Feni, 13.0% [95% CI, 13.0%-14.0%]). Across all age groups, male patients were at higher risk of prevalent DR than female patients (odds ratio, 1.99; 95% CI, 1.90-2.07). The prevalence was 3.9% for preproliferative DR, 7.8% for proliferative DR, and 19.2% for maculopathy. Individuals with DR had significantly worse visual acuity than those with no DR (best-corrected visual acuity, 0.35 vs 0.21 logMAR; P < .001). The rate of moderate visual impairment was 12.2%, and the rate of blindness was 2.5%. Primary treatments included laser photocoagulation (n = 1637), intravitreal injection (n = 1440), and vitrectomy (n = 309). Conclusions and Relevance: Screening Bangladeshi individuals known to have diabetes using fundus photography identified large numbers of patients with sight-threatening proliferative DR, maculopathy, and visual impairment or blindness. Expansion of eye screening services in Bangladesh is warranted as part of a national government eye care and diabetes health policy.

Indexed as

Visual AcuityAdolescentAdultAgedAged, 80 and overBangladeshChildCross-Sectional StudiesDiabetic RetinopathyFemaleFundus OculiHumansMaleMass ScreeningMiddle AgedPrevalence

Identifiers

PMID31774523
PMCPMC6902843
OpenAlexW2991417312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.